Rock Weekly: Like the letter of a jilted lover

rockweeklycropped
December 2, 2013

Over turkey dinners last week, the conversation turned to genomics and the tech surge. There was no shortage of opinions on the FDA’s letter to 23andMe (“It reads like the letter of a jilted lover,” said Duke professor Misha Angrist, while Matthew Herper penned the harshly titled “23andStupid?“), amid claims that the FDA had not heard from the company since May.

Not everyone took Thanksgiving off, as developers for Healthcare.gov worked over the holiday to meet the November 30th promise that the site would be functional for the majority of users.  Yesterday, the Obama administration said that they met their deadline for significant improvements to the site and that it was “night and day from where it was on October 1st.”

 

Headlines

The FDA vs. Personal Genetic Testing
The New Yorker

Inside the Race to Rescue a Health Care Site, and Obama
New York Times

Do Genetic Tests Need Doctors?
Bloomberg Businessweek

New Healthcare.gov CEO Sought
Politico

Pew Report: People Who Are Actually Sick Don’t Use High-Tech Health Tracking Devices
FastCompany

First Made-for-iPhone Hearing Aid Now Available
CNET

51 Digital Health Metrics in 2013
MobiHealthNews

Care.com Files Confidentially for IPO Next Year
Boston Business Journal

 

Funding

Name Amt Investors Source
WellRight $4M Undisclosed Press release
Catalyze.io $2M Baird Capital, Arthur Ventures, Chicago Ventures SEC
Dabo Health $1.9M Undisclosed SEC
Rest Devices $1.3M Experiment Fund and angels Wall Street Journal

 
Get the Rock Weekly for news and funding in digital health!
[gravityform id=”1″ name=”Stay in touch” title=”false” description=”false”]